Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pollard

Showing results (641-650 of 992) with videos related to

Pageof 100
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 20, 2010
Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancyJamie Findlow, Ray Borrow, Matthew D Snape, et al.
Vaccine|May 24, 2024
Decline in pneumococcal vaccine serotype carriage, multiple-serotype carriage, and carriage density in Nepalese children after PCV10 introduction: A pre-post comparison studyRama Kandasamy, Meeru Gurung, Sonu Shrestha, et al.
Clinical and Vaccine Immunology : CVI|December 20, 2013
Neisseria meningitidis native outer membrane vesicles containing different lipopolysaccharide glycoforms as adjuvants for meningococcal and nonmeningococcal antigensJerry C Nagaputra, Christine S Rollier, Manish Sadarangani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 8, 2019
Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infection Among Bangladeshi Children: A Protocol for a Phase IIIb TrialKatherine Theiss-Nyland, Firdausi Qadri, Rachel Colin-Jones, et al.
Plos One|December 20, 2012
Construction of Opa-positive and Opa-negative strains of Neisseria meningitidis to evaluate a novel meningococcal vaccineManish Sadarangani, J Claire Hoe, Martin J Callaghan, et al.
Medrxiv : the Preprint Server for Health Sciences|June 30, 2021
T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoirePhillip A Swanson, Marcelino Padilla, Wesley Hoyland, et al.
Plos One|February 3, 2015
Multi-serotype pneumococcal nasopharyngeal carriage prevalence in vaccine naïve Nepalese children, assessed using molecular serotypingRama Kandasamy, Meeru Gurung, Anushil Thapa, et al.
The Journal of Clinical Investigation|July 4, 2023
Molecular correlates of vaccine-induced protection against typhoid feverHenderson Zhu, Irina Chelysheva, Deborah L Cross, et al.
BMJ (Clinical Research Ed.)|June 7, 2008
Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational studyM D Snape, D F Kelly, S Lewis, et al.
Frontiers in Immunology|April 22, 2017
Challenge of Humans with Wild-type <i>Salmonella enterica</i> Serovar Typhi Elicits Changes in the Activation and Homing Characteristics of Mucosal-Associated Invariant T CellsRosângela Salerno-Goncalves, David Luo, Stephanie Fresnay, et al.
Pageof 100

Showing results (641-650 of 992) with videos related to

Sort By:
Pageof 100
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 20, 2010
Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancyJamie Findlow, Ray Borrow, Matthew D Snape, et al.
Vaccine|May 24, 2024
Decline in pneumococcal vaccine serotype carriage, multiple-serotype carriage, and carriage density in Nepalese children after PCV10 introduction: A pre-post comparison studyRama Kandasamy, Meeru Gurung, Sonu Shrestha, et al.
Clinical and Vaccine Immunology : CVI|December 20, 2013
Neisseria meningitidis native outer membrane vesicles containing different lipopolysaccharide glycoforms as adjuvants for meningococcal and nonmeningococcal antigensJerry C Nagaputra, Christine S Rollier, Manish Sadarangani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 8, 2019
Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infection Among Bangladeshi Children: A Protocol for a Phase IIIb TrialKatherine Theiss-Nyland, Firdausi Qadri, Rachel Colin-Jones, et al.
Plos One|December 20, 2012
Construction of Opa-positive and Opa-negative strains of Neisseria meningitidis to evaluate a novel meningococcal vaccineManish Sadarangani, J Claire Hoe, Martin J Callaghan, et al.
Medrxiv : the Preprint Server for Health Sciences|June 30, 2021
T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoirePhillip A Swanson, Marcelino Padilla, Wesley Hoyland, et al.
Plos One|February 3, 2015
Multi-serotype pneumococcal nasopharyngeal carriage prevalence in vaccine naïve Nepalese children, assessed using molecular serotypingRama Kandasamy, Meeru Gurung, Anushil Thapa, et al.
The Journal of Clinical Investigation|July 4, 2023
Molecular correlates of vaccine-induced protection against typhoid feverHenderson Zhu, Irina Chelysheva, Deborah L Cross, et al.
BMJ (Clinical Research Ed.)|June 7, 2008
Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational studyM D Snape, D F Kelly, S Lewis, et al.
Frontiers in Immunology|April 22, 2017
Challenge of Humans with Wild-type <i>Salmonella enterica</i> Serovar Typhi Elicits Changes in the Activation and Homing Characteristics of Mucosal-Associated Invariant T CellsRosângela Salerno-Goncalves, David Luo, Stephanie Fresnay, et al.
Pageof 100